Unknown EARLY_PHASE1 INTERVENTIONAL 1-arm NCT02335515

The Gastric Residence Time (GRT) of Soctec Capsule After a Standardized Breakfast

Gastric Retention Time of Floating Gastro-Retentive Capsules in Male Healthy Subjects After Breakfast as Measured by Magnetic Resonance Imaging (MRI)

Sponsor: SkyePharma AG

Conditions Healthy

Interventions Soctec

Updated 6 times since 2017 Last updated: Jan 8, 2015 Started: Sep 30, 2014 Primary completion: Oct 31, 2014 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Healthy and is currently ongoing. SkyePharma AG leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status EARLY_PHASE1
Feb 2017 — Jun 2018 [monthly]

Unknown Status EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status Phase 0

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SkyePharma AG
University of Zurich

Data source: SkyePharma AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.